Nina M. Hill is an independent consultant and the former Vice President of Innovation Policy, Global Policy at Pfizer, which places the advancement of human health at the center of global life sciences policy development. She was a member of the Pfizer Bioethics Advisory Panel and was the founding editor of the Value of Medicines at Pfizer.com. Her work addressed unmet policy needs in clinical trials, compassionate access, precision medicine, vaccines, anti-microbial resistance and Medicare.
Prior to joining Pfizer, as a director of the International Center for the Disabled, she led the social policy research with the National Council on Disability, that helped secure passage of the 1990 Americans with Disabilities Act. As a former leader of the March of Dimes in NYC, she worked to advanced maternal and infant health by advocating for expanded Medicaid coverage and SCHIP.
Previous memberships include the MRCT Executive Committee and Bioethics Collaborative, and board memberships of the National Health Council, the Alliance for Aging Research and INCLUDEnyc.
She is a recipient of the Huntington’s Disease Society of America Guthrie Family Humanitarian Award, the National Coalition of Women with Heart Disease Corporate Leadership Award, the Arthritis Foundation Patient Services Award, Rotary International Award for Outstanding Work with Children in Need and the Freedom of the Human Spirit award from INCLUDEnyc.
Holding a Ph.D. in Speech Science from Columbia University, she earned an MIT Certificate in Artificial Intelligence Business Strategies. She is a published author and graduate of the Executive Program, Columbia University Graduate School of Business and the Harvard Business School Pfizer Leadership Development Program.
Nina’s appointment on the MRCT Center’s EAB is effective as of March 3, 2020.